These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36688363)

  • 41. Factors affecting clinical pregnancy in controlled ovarian hyperstimulation with GnRH-a long protocol: a retrospective cross-sectional study.
    Fan Y; Sun YF; Xu YM; Cao ZY; Luo ZY; Sun Y; Zhao ZM; Hao GM; Gao BL
    J Obstet Gynaecol; 2022 Aug; 42(6):2486-2491. PubMed ID: 35678767
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study.
    Lan J; Wu Y; Wu Z; Wu Y; Yang R; Liu Y; Lin H; Jiao X; Zhang Q
    Front Endocrinol (Lausanne); 2021; 12():609771. PubMed ID: 34135858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gonadotropin-releasing hormone antagonist protocol in patients with risk of poor response to ovarian stimulation in IVF-ET].
    Sun Y; Zhu YM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 May; 38(3):305-10. PubMed ID: 19504641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of duration of gonadotropin releasing hormone agonist on the outcome of in vitro fertilization-embryo transfer in a short-acting long regimen.
    Mu ZN; Sun ZG; Song JY; Liu HG; Qiao Y; Xia QC
    Libyan J Med; 2019 Dec; 14(1):1652058. PubMed ID: 31405338
    [No Abstract]   [Full Text] [Related]  

  • 45. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of IVF/ICSI Outcomes in Endometriosis Patients With Recurrent Implantation Failure: Influence on Cumulative Live Birth Rate.
    Zhong C; Gao L; Shu L; Hou Z; Cai L; Huang J; Liu J; Mao Y
    Front Endocrinol (Lausanne); 2021; 12():640288. PubMed ID: 34393990
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolonged pituitary downregulation with gonadotropin-releasing hormone agonist improves the live-birth rate: a retrospective cohort study comparing 3 different protocols.
    Ruan M; Fang L; Yang S; Chen Z; Wu Y; Qu X; Zhao J; Cheng J
    Ann Palliat Med; 2021 Sep; 10(9):9984-9992. PubMed ID: 34628922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Repeated superovulation induction after failure in previous IVF-ET cycles with the ultra-long protocol: Analysis of outcomes of clinical pregnancy].
    Wang B; Kong N; Liu JY; Zhang NY; Zhu YC; Zhou JJ
    Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1099-1102. PubMed ID: 29738181
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of luteal phase ovulation induction and ultra-short gonadotropin-releasing hormone agonist protocols in older patients undergoing in vitro fertilization.
    Wang T; Sun Z; Lim JP; Yu Y
    Libyan J Med; 2019 Dec; 14(1):1597327. PubMed ID: 30935302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of the Long-Acting GnRH Agonist Follicular Protocol with the GnRH Antagonist Protocol in Women Undergoing In Vitro Fertilization: A Systematic Review and Meta-analysis.
    Yang R; Guan Y; Perrot V; Ma J; Li R
    Adv Ther; 2021 May; 38(5):2027-2037. PubMed ID: 33651282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of IVF/ICSI Cycles: A retrospective study.
    Duan L; Bao S; Li K; Teng X; Hong L; Zhao X
    J Obstet Gynaecol Res; 2017 Jun; 43(6):1037-1042. PubMed ID: 28422380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is early-follicular long-acting GnRH agonist protocol an alternative for patients with polycystic ovary syndrome undergoing in vitro fertilization?
    Wang D; Chu T; Yu T; Zhai J
    Reprod Biol Endocrinol; 2022 Sep; 20(1):137. PubMed ID: 36088329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Dual Trigger In Vitro Fertilization and Intracytoplasmic Sperm Injection During the Gonadotropin-releasing Hormone-Antagonist Cycle on Final Oocyte Maturation and Cumulative Live Birth Rate in Women with Diminished Ovarian Reserve.
    Ren YM; Wang YB; Fu M; Zhang QX; Shen H; Han HJ; Gao FM
    Curr Med Sci; 2022 Oct; 42(5):1066-1070. PubMed ID: 35997911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China.
    Yang J; Zhang X; Ding X; Wang Y; Huang G; Ye H
    Reprod Biol Endocrinol; 2021 Aug; 19(1):124. PubMed ID: 34384445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GnRH agonist administration prior to embryo transfer in freeze-all cycles of patients with endometriosis or aberrant endometrial integrin expression.
    Surrey ES; Katz-Jaffe M; Kondapalli LV; Gustofson RL; Schoolcraft WB
    Reprod Biomed Online; 2017 Aug; 35(2):145-151. PubMed ID: 28601378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproductive Outcome After GnRH Agonist Triggering With Co-Administration of 1500 IU hCG on the Day of Oocyte Retrieval in High Responders: A Long-Term Retrospective Cohort Study.
    Abdulkhalikova D; Bokal EV; Stimpfel M; Ciglar P; Korosec S
    Front Endocrinol (Lausanne); 2022; 13():826411. PubMed ID: 35464066
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.
    Ye H; Huang GN; Zeng PH; Pei L
    J Assist Reprod Genet; 2009 Mar; 26(2-3):105-11. PubMed ID: 19225876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.